Latest Naltrexone Stories
- Contrave® net sales total $6.5 million in first 10 weeks of launch SAN DIEGO, Feb. 25, 2015 /PRNewswire/ -- Orexigen Therapeutics, Inc.
SAN DIEGO, Feb. 9, 2015 /PRNewswire/ -- Orexigen Therapeutics, Inc.
A research team led by the University of Colorado Boulder has discovered a mechanism in the brain that is key to making cocaine seem pleasurable, a finding that could lead to a drug treatment
ORLANDO, Fla. and DUBLIN, Jan. 23, 2015 /PRNewswire/ -- Immune Therapeutics, Inc. today announced the signing of the agreement with KRS Global Biotechnology, Inc.
LA JOLLA, Calif., Dec.
- Patent for naltrexone SR formulation expected to extend Contrave protection to 2028 SAN DIEGO, Nov. 21, 2014 /PRNewswire/ -- Orexigen Therapeutics, Inc.
SAN DIEGO, Nov. 10, 2014 /PRNewswire/ -- Orexigen(®) Therapeutics, Inc.
LA JOLLA, Calif., Oct.
DUBLIN, October 30, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/g7lhzm/global_and ) has announced the addition of the "Global
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.